Roger K Cady Selected Research

Roger K Cady Research Topics

Disease

47	Migraine Disorders (Migraine) 03/2021 - 11/2002
26	Headache (Headaches) 12/2017 - 11/2002
17	Pain (Aches) 12/2017 - 11/2002
4	Epilepsy (Aura) 12/2017 - 01/2007
3	Photophobia (Light Sensitivity) 12/2017 - 02/2007
3	Nausea 12/2017 - 02/2007
3	Hyperacusis (Phonophobia) 12/2017 - 02/2007
3	Headache Disorders (Headache Syndromes) 12/2017 - 05/2004
2	Secondary Headache Disorders 08/2013 - 11/2009
2	Dysmenorrhea (Menstrual Pain) 05/2011 - 07/2009
2	Fatigue 02/2009 - 02/2007
2	Sleepiness 10/2008 - 02/2007
1	Paresthesia (Dysesthesia) 12/2017
1	Neck Pain (Cervicalgia) 12/2017
1	Flushing 12/2017
1	Ganglion Cysts (Ganglion) 04/2015
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 06/2012
1	Celiac Disease (Celiac Sprue) 06/2012
1	Migraine without Aura (Common Migraine) 04/2012
1	Hyperalgesia 03/2009
1	Heartburn (Pyrosis) 02/2009
1	Gastroesophageal Reflux (GERD) 02/2009
1	Nasopharyngitis 02/2009
1	Dizziness (Lightheadedness) 10/2008
1	Vomiting 02/2007
1	Rhinosinusitis 01/2006

Drug/Important Bio-Agent (IBA)

15	Tryptamines (Triptans)IBA 12/2017 - 04/2004
12	Sumatriptan (Imigran)FDA LinkGeneric 12/2017 - 11/2002
8	TabletsIBA 05/2015 - 01/2007
8	Pain-FreeIBA 09/2011 - 11/2002
6	Topiramate (Topamax)FDA LinkGeneric 02/2014 - 11/2007
5	sumatriptan-naproxen FDA Link 04/2014 - 01/2007
5	rizatriptan (Maxalt)FDA Link 01/2012 - 05/2009
4	Calcitonin Gene-Related PeptideIBA 03/2021 - 01/2006
4	Type A Botulinum Toxins (Botox)FDA Link 02/2014 - 02/2010
4	almotriptan (Axert)FDA Link 03/2009 - 02/2007
3	frovatriptan (Allegro)FDA Link 01/2016 - 11/2009
3	Naproxen (Naprosyn)FDA LinkGeneric 04/2014 - 07/2009
3	SodiumIBA 04/2014 - 01/2007
2	PowdersIBA 05/2015 - 01/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2009 - 02/2009
2	Valproic Acid (Depakote)FDA LinkGeneric 02/2009 - 07/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2009 - 01/2007
1	Monoclonal AntibodiesIBA 03/2021
1	eptinezumabIBA 03/2021
1	AntibodiesIBA 01/2019
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2019
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	DFN-02IBA 12/2017
1	PlacebosIBA 08/2016
1	salicylhydroxamic acid (SHAM)IBA 08/2016
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 04/2015
1	Lactose FDA LinkGeneric 01/2015
1	preemptIBA 08/2013
1	Glutens (Glutelin)IBA 06/2012
1	Dosage Forms (Dosage Form)IBA 11/2011
1	Analgesics (Analgesic Drugs)IBA 11/2009
1	P-430IBA 05/2009
1	S-2-O-carbamoyl-1-o-chlorophenyl-ethanolIBA 02/2009
1	Prescription DrugsIBA 02/2009
1	Ethanol (Ethyl Alcohol)IBA 02/2009
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2009
1	eletriptan (Relpax)FDA Link 05/2007
1	Caffeine (No Doz)FDA LinkGeneric 01/2007
1	KetorolacIBA 01/2007
1	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2007
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2007
1	butalbital FDA LinkGeneric 01/2007
1	NeuropeptidesIBA 01/2006
1	Pseudoephedrine FDA LinkGeneric 01/2006
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2006
1	Indicators and Reagents (Reagents)IBA 05/2004

Therapy/Procedure

13	Therapeutics 04/2012 - 11/2002
4	Aftercare (After-Treatment) 11/2007 - 09/2005
1	Intravenous Administration 03/2021
1	Vagus Nerve Stimulation 08/2016
1	Drug Therapy (Chemotherapy) 02/2010
1	Injections 11/2009
1	Time-to-Treatment 03/2009
1	Treatment Delay 11/2002